Literature DB >> 10886084

Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer.

D Unal1, J P Sedelaar, R G Aarnink, G J van Leenders, H Wijkstra, F M Debruyne, J J de la Rosette.   

Abstract

OBJECTIVE: To investigate the value of three-dimensional contrast-enhanced power Doppler ultrasonography (3D-CE-PDU) in the diagnosis of prostate cancer and to compare 3D-CE-PDU with digital rectal examination (DRE), prostate-specific antigen (PSA) levels, grey-scale ultrasonography (GSU) and PDU. PATIENTS AND METHODS: The study comprised 30 patients with localized prostate cancer scheduled to undergo radical prostatectomy and 29 with clinical BPH scheduled to undergo transurethral microwave thermotherapy. The 3D-CE-PDU examinations were carried out using 2.5 g of microbubble ultrasound contrast medium; the images were stored digitally to allow off-line analysis. All the reconstructed 3D images of the prostate were evaluated blindly in random order by two investigators (one expert and one novice). The images were scored according to asymmetry (0-2) and vessel distribution (0-3). Marked asymmetry (2) and/or a focal increase in vascularity (> 2) were considered as suspicious for prostate malignancy. Diagnostic predictions using the DRE, PSA level, GSU, PDU, 3D-CE-PDU and their combinations were investigated using receiver operating characteristic (ROC) curves.
RESULTS: True-positive and true-negative rates of the 3D-CE-PDU were 87% (26/30) and 79% (23/29), respectively, for the expert observer. The sensitivity of 3D-CE-PDU was higher than that of DRE, GSU and PDU, but not PSA level, and the specificity was lower, again except for PSA level. However, when compared with those of the other modalities in single-test evaluations, 3D-CE-PDU, and a combination of 3D-CE-PDU and PSA level, had the largest area under the ROC curve (0. 830 and 0.933, respectively). The diagnostic agreement between the examiners was 76% (Cohen kappa statistic, 0.5).
CONCLUSION: In this selected group of patients, 3D-CE-PDU alone was a better diagnostic tool than the DRE, PSA level, GSU or PDU alone. The most suitable diagnostic predictor for prostate cancer was a combination of 3D-CE-PDU and PSA level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886084     DOI: 10.1046/j.1464-410x.2000.00719.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

1.  [Transrectal ultrasound of the prostate. Current status and prospects].

Authors:  M Zacharias; K V Jenderka; H Heynemann; P Fornara
Journal:  Urologe A       Date:  2002-11       Impact factor: 0.639

Review 2.  Three dimensional ultrasound and prostate cancer.

Authors:  S S Mehta; A R Azzouzi; F C Hamdy
Journal:  World J Urol       Date:  2004-11-12       Impact factor: 4.226

Review 3.  [Ultrasound contrast agents and prostate cancer].

Authors:  F Frauscher; L Pallwein; A Klauser; A P Berger; F Koppelstaetter; J Gradl; M Schurich; J Bektic; G M Pinggera; E J Halpern; W Horninger; G Bartsch; D zur Nedden
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 4.  [Innovative concepts in early cancer detection and staging of localized prostate cancer].

Authors:  L Rinnab; R Küfer; R E Hautmann; B G Volkmer; M Straub; N M Blumstein; H W Gottfried
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

Review 5.  Contrast specific imaging in the detection and localization of prostate cancer.

Authors:  Hessel Wijkstra; Margot H Wink; Jean J M C H de la Rosette
Journal:  World J Urol       Date:  2004-10-05       Impact factor: 4.226

6.  Applications of transrectal ultrasound in prostate cancer.

Authors:  C J Harvey; J Pilcher; J Richenberg; U Patel; F Frauscher
Journal:  Br J Radiol       Date:  2012-07-27       Impact factor: 3.039

Review 7.  Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer.

Authors:  M H Wink; J J M C H de la Rosette; C A Grimbergen; H Wijkstra
Journal:  World J Urol       Date:  2007-06-27       Impact factor: 4.226

Review 8.  How to improve prostate biopsy detection of prostate cancer.

Authors:  D K Ornstein; J Kang
Journal:  Curr Urol Rep       Date:  2001-06       Impact factor: 3.092

9.  Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer.

Authors:  Masahiko Inahara; Hiroyoshi Suzuki; Hiroshi Nakamachi; Naoto Kamiya; Masaki Shimbo; Akira Komiya; Takeshi Ueda; Tomohiko Ichikawa; Koichiro Akakura; Haruo Ito
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 10.  Ultrasound of prostate cancer: recent advances.

Authors:  Leo Pallwein; Michael Mitterberger; Alexandre Pelzer; Georg Bartsch; Hannes Strasser; Germar M Pinggera; Friedrich Aigner; Johann Gradl; Dieter Zur Nedden; Ferdinand Frauscher
Journal:  Eur Radiol       Date:  2007-10-16       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.